Myosin regulatory light chain (RLC) phosphorylation is important for cardiac muscle mechanics/function as well as for the Ca 2+ -troponin/tropomyosin regulation of muscle contraction. This study focuses on the arginine to glutamine (R58Q) substitution in the human ventricular RLC (MYL2 gene), linked to malignant hypertrophic cardiomyopathy in humans and causing severe functional abnormalities in transgenic (Tg) R58Q mice, including inhibition of cardiac RLC phosphorylation. Using a phosphomimic recombinant RLC variant where Ser-15 at the phosphorylation site was substituted with aspartic acid (S15D) and placed in the background of R58Q, we aimed to assess whether we could rescue/mitigate R58Q-induced structural/functional abnormalities in vitro. We show rescue of several R58Q-exerted adverse phenotypes in S15D-R58Q-reconstituted porcine cardiac muscle preparations. A low level of maximal isometric force observed for R58Q-versus WTreconstituted fibers was restored by S15D-R58Q. Significant beneficial effects were also observed on the V max of actin-activated myosin ATPase activity in S15D-R58Q versus R58Q-reconstituted myosin, along with its binding to fluorescently labeled actin. We also report that R58Q promotes the OFF state of myosin, both in reconstituted porcine fibers and in Tg mouse papillary muscles, thereby stabilizing the super-relaxed state (SRX) of myosin, characterized by a very low ATP turnover rate. Experiments in S15D-R58Q-reconstituted porcine fibers showed a mild destabilization of the SRX state, suggesting an S15D-mediated shift in disordered-relaxed (DRX)↔SRX equilibrium toward the DRX state of myosin. Our study shows that S15D-phosphomimic can be used as a potential rescue strategy to abrogate/ alleviate the RLC mutation-induced phenotypes and is a likely candidate for therapeutic intervention in HCM patients.
Myosin regulatory light chain (RLC) phosphorylation is important for cardiac muscle mechanics/function as well as for the Ca 2+ -troponin/tropomyosin regulation of muscle contraction. This study focuses on the arginine to glutamine (R58Q) substitution in the human ventricular RLC (MYL2 gene), linked to malignant hypertrophic cardiomyopathy in humans and causing severe functional abnormalities in transgenic (Tg) R58Q mice, including inhibition of cardiac RLC phosphorylation. Using a phosphomimic recombinant RLC variant where Ser-15 at the phosphorylation site was substituted with aspartic acid (S15D) and placed in the background of R58Q, we aimed to assess whether we could rescue/mitigate R58Q-induced structural/functional abnormalities in vitro. We show rescue of several R58Q-exerted adverse phenotypes in S15D-R58Q-reconstituted porcine cardiac muscle preparations. A low level of maximal isometric force observed for R58Q-versus WTreconstituted fibers was restored by S15D-R58Q. Significant beneficial effects were also observed on the V max of actin-activated myosin ATPase activity in S15D-R58Q versus R58Q-reconstituted myosin, along with its binding to fluorescently labeled actin. We also report that R58Q promotes the OFF state of myosin, both in reconstituted porcine fibers and in Tg mouse papillary muscles, thereby stabilizing the super-relaxed state (SRX) of myosin, characterized by a very low ATP turnover rate. Experiments in S15D-R58Q-reconstituted porcine fibers showed a mild destabilization of the SRX state, suggesting an S15D-mediated shift in disordered-relaxed (DRX)↔SRX equilibrium toward the DRX state of myosin. Our study shows that S15D-phosphomimic can be used as a potential rescue strategy to abrogate/ alleviate the RLC mutation-induced phenotypes and is a likely candidate for therapeutic intervention in HCM patients.
Introduction
Familial Hypertrophic Cardiomyopathy (HCM), a primary disorder of cardiac myocytes, is an autosomal dominant disease manifested by ventricular hypertrophy, myofibrillar disarray, myocardial fibrosis, and sudden cardiac death (SCD), especially in young athletes [1, 2] . Genetic mutations that cause HCM primarily reside in b-myosin heavy chain (b-MHC) and myosin binding protein C (MyBP-C), but they are also present, with lower prevalence, in the myosin regulatory (RLC) and essential light chains (ELC) [3] [4] [5] . Both light chains stabilize the a-helical myosin neck region (lever arm), binding to their respective IQXXXRGXXXR motifs [6] , but they also play important modulatory roles of tuning myosin crossbridge (XB) kinetics and force-producing actin-myosin interactions. The N-terminal domain of the human ventricular RLC contains a divalent cation binding site and a myosin light chain kinase (MLCK)-specific phosphorylation site at Ser-15 [7] . A wealth of studies indicate that phosphorylation of myosin RLC is critical for the normal function of the heart, and that the myocardium containing dephosphorylated RLC has a reduced ability to produce force and maintain cardiac function at physiological levels (reviewed in [8] ). Significantly depressed RLC phosphorylation was reported in heart failure (HF) patients [9] and was also observed in experimental animal models of cardiac disease [10] [11] [12] . Studies in mice showed that reduced RLC phosphorylation resulted in abnormal heart performance, presumably through morphological and/or myofibrillar functional alterations such as change in force, myofilament calcium sensitivity, ATPase activity and XB kinetics [13] [14] [15] [16] . It has also been shown that overexpression of heart-specific small subunit of myosin light chain phosphatase (hHS-M 21 ) in mice results in myocardial fibrosis, arrhythmias and HF, mainly due to the dephosphorylation of cardiac RLC and a contributing nonmyosin RLC phosphorylation-dependent regulation [17] . The mechanistic basis for this phenomenon is likely the decreased ability of dephosphorylated myosin to efficiently execute the power stroke and generate enough force to maintain normal heart function compared with phosphorylated myosin containing physiological levels of RLC phosphorylation, i.e.,~0.4 mole Pi per mole RLC [13, 18] .
Significant genetic heterogeneity of HCM as well as phenotypic variability with varying extent, distribution and severity of the disease have led to poor prediction of clinical outcomes [19] . It is therefore important to elucidate the etiology of HCM at the molecular level for better understanding of the disease mechanisms and for development of potential therapeutic targets. This study is focused on HCM-linked R58Q (Arg? Gln) mutation in the human cardiac RLC (MYL2 gene), identified by Flavigny and Hainque, in unrelated French families [20] . The patients presented with increased left ventricular (LV) wall thickness, abnormal ECG findings (with no mid LV obstruction) and occurrences of SCD [20] . R58Q was later found in German, Swedish, and Italian populations and has been consistently associated with a phenotype of severe cardiomyopathy and cardiac death among family members [21] [22] [23] [24] .
In the three-dimensional structure of RLC, the R58Q mutation is located in the immediate extension of the exiting helix flanking the Ca 2+ binding loop. Our previous studies showed an R58Q-induced decrease in RLC phosphorylation, as measured in rapidly frozen ventricular heart samples from transgenic (Tg) R58Q mice [25] . In the present study, we aimed to determine whether the recombinant phosphomimic S15D-R58Q RLC variant containing aspartic acid substituted for serine-15 (S15D) [12, 26, 27] in the background of R58Q mutation can rescue/alleviate the detrimental phenotypes observed for R58Q mutant alone. Our approach was based on our previous observation that the constitutive phosphorylation by S15D substitution of another HCM-linked D166V-RLC mutant was sufficient to prevent the development of HCM in mice [12, 28] . Systolic and diastolic indices assessed via echocardiography and invasive hemodynamics demonstrated significant improvements in heart function in S15D-D166V mice compared with HCM-D166V mice [12] . Depressed maximal tension and abnormally high myofilament Ca 2+ sensitivity observed in HCM-D166V hearts were abrogated in S15D-D166V mice. Further studies with low-angle X-ray diffraction suggested that altered myofilament structures in HCM-D166V mice were partially or fully reversed in S15D-D166V mice [12] . The central hypothesis underlying these observations and directing our current research is that RLC phosphomimic, when placed in the background of an HCM-causing mutation, may play important roles in rescuing/mitigating functional HCM-associated defects.
Here, we addressed this hypothesis and tested the beneficial effect of constitutive RLC phosphorylation using porcine cardiac muscle preparations depleted of endogenous RLC and reconstituted with phosphomimic S15D-R58Q variant. The results were compared to those obtained from R58Q mutant alone and WT-RLC. The study was performed at different levels of system organization (RLC protein, myosin, muscle fiber), allowing for a comprehensive characterization of the rescue effects via S15D-RLC pseudophosphorylation in vitro. We found a multitude of rescue of R58Q-induced adverse phenotypes, including rescue of inhibition of the actin-myosin interaction in rigor (no ATP) and in the actin-activated myosin ATPase activity by S15D-R58Q. Similar rescue effects were monitored in S15D-R58Q-reconstituted skinned porcine papillary muscles (PM) which demonstrated recovery of R58Q-induced decrease in contractile force. To assess the effect of R58Q mutation on the stability of the sequestered, super-relaxed (SRX) state of myosin [29, 30] , we performed mant-ATP chase experiments in both mouse fibers isolated from Tg R58Q versus wildtype (WT) mice, as well as in RLC-depleted and mutant-reconstituted porcine PM. The results from both systems showed an R58Q-mediated stabilization of the SRX state of myosin. With a lack of available S15D-R58Q Tg animal model and using mutantreconstituted porcine PM, we demonstrated an S15D-R58Q-induced inhibition of the SRX state and a switch from the OFF to ON state of a small population of S15D-R58Q myosin heads.
Results
Effect of R58Q and S15D-R58Q mutations on the secondary structure of human cardiac RLC I-TASSER was used for the analysis of the five lowestenergy secondary structures of human ventricular RLC. The structures were computed using protein templates extracted from the Protein Data Bank (PDB). The following PDB structures with high similarity to RLC were used: PDB ID 3jvtB (chain B, calcium-bound scallop myosin regulatory domain (lever arm) with reconstituted complete light chains), PDB ID 2w4aA (chain A, isometrically contracting insect asynchronous flight muscle), PDB ID 1prwA (chain A, crystal structure of bovine brain Ca 2+ -calmodulin in a compact form), PDB ID 2mysB (chain B, myosin subfragment 1), PDB ID 4mvfA (chain A, crystal structure of Plasmodium falciparum CDPK2 complexed with inhibitor staurosporine), PDB ID 4agrA (chain A, structure of a tetrameric galectin from Cinachyrella sp. -Ball sponge), PDB ID 4ik1A (chain A, high-resolution structure of Gcampj at pH 8.5) [31, 32] . Figure 1A shows the predicted modeled structures of human ventricular RLCs (WT, R58Q and S15D-R58Q). Interestingly, the R58Q mutation results in a decrease in the apparent distance between the site of the mutation and Ser-15. In S15D-R58Q modeled structure, this distance is reversed close to that observed for RLC-WT (UniProtKB P10916).
Circular dichroism (CD) measurements
Far-UV Circular Dichroism spectroscopy was performed to detect any changes in the secondary structure of the human cardiac RLC-WT, R58Q, and S15D-R58Q recombinant proteins. The effect of the R58Q mutation on the secondary structure of RLC-WT was quantified from changes in the mean residue ellipticity at 222 nm, which has been shown to be sensitive to changes in the a-helical content of the protein. As presented in Fig. 1B , R58Q mutation did not result in any significant changes in the CD spectrum, and the calculated a-helical content (in % AE SD) was 18.74 AE 0.87 compared to WT which was 18.01 AE 0.43 and S15D-R58Q which was 18.69 AE 0.12 (P > 0.05, one-way ANOVA Binding of porcine cardiac myosin reconstituted with RLCs to pyrene-labeled F-actin Porcine cardiac myosin was depleted of endogenous RLC and then reconstituted with recombinant RLC proteins. Treatment of the native porcine myosin resulted in depletion of approximately 80% RLC. Several batches of RLC-reconstituted myosin were used for this assay ( Fig. 2A) . Incubation of depleted myosin with recombinant RLC proteins resulted in up to~87% reconstitution, as judged by band intensities and the ratio of ELC to RLC in the reconstituted versus native myosin ( Fig. 2A) . The ability of RLC-depleted myosin, which underwent the extraction procedure, to bind recombinant RLC variants is quantified in Table 1 .
Myosins reconstituted with R58Q, S15D-R58Q, and WT RLCs were then tested for their interaction with actin. First, fluorescence-based binding assays of reconstituted myosins to pyrene-labeled F-actin were conducted under rigor (no ATP) conditions to assess changes induced by the R58Q mutation and its S15D-R58Q phosphomimic variant on the binding affinity. A decrease in the fluorescence intensity induced by the binding of myosin to F-actin was measured as a function of increasing myosin concentrations (Fig. 2B) . Results showed a strong inhibition of the actin-myosin binding by R58Q mutant compared to WT-reconstituted myosin and demonstrated by significantly higher apparent dissociation constant (K d~1 3 nM) for R58Q versus control WT protein (K d~2 nM; Fig. 2C ; Table 2 ). For the double S15D-R58Q mutant, the observed binding to F-actin with K d~4 nM, was comparable to that obtained for WT control but was significantly different from R58Q mutant (P < 0.0001, by one-way ANOVA with Tukey's multiple comparison test; Fig. 2C and Table 2 ). These results indicate the rescue in binding affinity by phosphomimic RLC in the background of R58Q mutation.
Actin-activated myosin ATPase assays
To measure the effect of mutation and pseudophosphorylation of RLC in the background of mutation on ATPase enzymatic activity, F-actin-activated myosin ATPase activity assays were performed on porcine cardiac myosin preparations reconstituted with human recombinant RLC proteins: WT, R58Q, and S15D-R58Q ( Fig. 2D; (Table 2) .
Stopped-flow measurements
To further characterize interaction of reconstituted porcine myosins with actin, we measured the dissociation rates (k obs ) of myosin (at concentration 0.25 lM) bound to pyrene-labeled F-actin (0. , and S15D-R58Q, using I-TASSER. Note that the distance between the C-a of R58 and S15 is changed in HCM-R58Q mutant and that the phosphomimic variant reverses this value close to the level of WT. (B) Effect of the R58Q mutation and S15D-R58Q phosphomimic on the CD spectra of human cardiac RLC. Far-UV CD was performed utilizing a 1-mm path quartz cell in a Jasco J-720 spectropolarimeter. from actin on the addition of Mg-ATP. Figure 2E presents dissociation rates (k obs )-[Mg-ATP] dependence for WT, R58Q, and S15D-R58Q RLCs. The observed dissociation rates (k obs in s
À1
) derived from the averaged fluorescence traces and fitted with a single exponential are presented in Table 3 . Compared to WT, Note the significantly higher K d (lower affinity) for R58Q mutation, which is offset in the presence of S15D phosphomimic. ****P < 0.0001 versus WT, S15D-R58Q for n = 4-6, by one-way ANOVA with Tukey's multiple comparison test. (D) Actin-activated myosin ATPase activity.
Reconstituted myosins (at concentration of 1.1 lM) were incubated with increasing concentrations of actin (0.1-20 lM) and assayed for actin-activated myosin ATPase activity. The reactions were initiated with the addition of 2.5 mM ATP. Note that a significantly lower V max observed for R58Q mutation was rescued in the presence of the phosphomimic S15D-R58Q. Data are the average AE SEM of n = 12-17 independent experiments; ****P < 0.0001 versus WT, S15D-R58Q; by one-way ANOVA with Tukey's multiple comparison test. No significant differences in K m were observed among the groups. (E) Stopped-flow measurements of actomyosin dissociation. Fast kinetic interactions between porcine myosin reconstituted with recombinant RLC proteins (WT, R58Q, and S15D-R58Q) and pyrene-labeled F-actin. Dissociation rates (k obs ) were plotted as a function of [Mg-ATP] = from 10 to 250 lM. The values of k obs AE SEM for each Mg-ATP concentration are presented in Table 4 . No significant differences were found between the overall fits among the RLCs (Extra sum-ofsquares F-test, P > 0.05). R58Q mutant-reconstituted myosin showed significantly slower transition rate at 150 lM Mg-ATP while S15D-R58Q-reconstituted myosin demonstrated rates greater than that for R58Q (Table 3) . No other notable differences were noted for any other Mg-ATP concentrations and we believe that despite a change at 150 lM, R58Q does not alter dissociation rates compared to WT. Comparison of independent fits for different RLCs-reconstituted myosin with a global fit (sharing K 1 and K max ) did not reveal any significant differences between the overall fits among all tested RLCs (Fig. 2E , Extra sum-ofsquares F-test, P > 0.05).
Steady-state force measurements
Measurements of steady-state force generation and calcium sensitivity of force were performed on skinned PM strips depleted of RLC and reconstituted with RLC mutant proteins ( Fig. 3 ; Table 4 ). Figure 3A shows representative SDS/PAGE images of CDTA-depleted and RLC/TnC (Troponin C)-reconstituted porcine PM. Reconstitution with TnC was necessary to make sure that the changes in force were not due to TnC deficiency [33] . On average,~17% of porcine RLC remained in the fibers, which were subsequently incubated with recombinant RLC proteins. The reconstitution levels achieved in RLC-depleted and mutant-reconstituted PM for WT, R58Q, and S15D-R58Q are shown in Table 1 . Percent reconstitution was calculated according to SDS/PAGE band densities of the RLC and ELC proteins (Fig. 3A) . The ELC/RLC ratios were compared with those of control-untreated muscle strips. ELC protein was used as a loading control as it was not affected by the RLC extraction/reconstitution procedure. A significantly lower maximal isometric force per cross-section of muscle (in kNÁm
À2
) was observed for R58Q-reconstituted porcine muscle preparations (~34) compared to WT (~41) with P < 0.01 by one-way ANOVA (Table 4) . Upon reconstitution with the phosphomimetic S15D-R58Q, porcine muscle strips demonstrated rescue mechanism, manifested by a significantly higher and similar to WT level of maximal tension (~44; Fig. 3B ). The pCa 50 values, presented in Fig. 3C and Table 4 , were not significantly different among the three groups (Fig. 3D) .
Measurements of nucleotide turnover rate and the super-relaxed (SRX) state using fluorescent mant-ATP chase assay
We also assessed the effect of R58Q mutation on the SRX state of myosin in porcine PM fibers (Fig. 4 ) and in Tg mouse papillary muscles (Fig. 5) . With a lack of available S15D-R58Q Tg animal model, the effect of S15D-R58Q double mutant was investigated in RLCdepleted and S15D-R58Q-reconstituted porcine PM fibers.
Skinned porcine cardiac PM fibers, RLC-depleted and reconstituted with recombinant WT, R58Q, S15D-R58Q proteins were incubated in a relaxing solution containing 250 lM mant-ATP. Then the fibers were mounted in a flow cell of the IonOptix apparatus and subjected to nucleotide exchange assay using 4 mM dark ATP-relaxing solution (Fig. 4) . Decay in fiber fluorescence was recorded as the mant-nucleotide was released from myosin and replaced by dark ATP [34] . Figure 4A -D shows the time-dependent average fluorescence decay curves for WT (blue trace), R58Q (red trace), and S15D-R58Q (green trace) during the chase phase with nonfluorescent ATP. The decay of fluorescence intensity was fitted to the following doubleexponential function:
where P 1 and P 2 are the relative fiber fluorescence fractions (amplitudes) of the two states: DRX (disordered-relaxed) and SRX (super-relaxed) and T 1 and T 2 depict their respective lifetimes (in seconds; Fig. 4 and Table 4 ). The P 1 and P 2 values (in %) illustrate the population of myosin heads in DRX and SRX states, respectively.
Simulated single-exponential dashed curves for the fast phase (black) and slow phase (orange) for each protein were derived from fluorescence decay rates (1/ T) obtained from fitting the experimental doubleexponential curves to single-exponential fits (Fig. 4) . As shown in Table 4 , R58Q-reconstituted porcine fibers significantly increased the proportion of myosin heads in the SRX state with P 2 = 40% for R58Q compared to 26% for WT fibers. The presence of S15D in the background of the mutation (S15D-R58Q) led to destabilization of SRX and the shift of myosin heads toward the DRX state with P 2 = 30% ( Fig. 4E ; Table 4 ). No significant differences in lifetimes for both phases among WT, R58Q, and S15D-R58Q were observed. Studies in Tg R58Q versus WT PM mouse fibers (Fig. 5A-D) confirmed the R58Q-induced stabilization of the SRX state of myosin with P 2 = 53% in R58Q compared with P 2 = 38% in WT mice (Table 4 ). The differences in P 1 and P 2 for R58Q versus WT animals were statistically significant ( Fig. 5D ; Table 4 ), providing evidence for the mutation-induced promotion of the sequestered, SRX state and a decrease in the population of myosin heads existing in the DRX state.
Discussion
In order to investigate the potential role of RLC pseudophosphorylation in rescuing and/or mitigating HCM mutation-induced abnormalities in vitro, we used -sensitivity of force was observed for R58Q-reconstituted fibers compared with WT. Reconstitution with S15D-R58Q increased maximal tension to the level observed for WT fibers. Data are the average AE SEM of n = 10 fibers per group. **P < 0.01 (R58Q versus WT), ***P < 0.001 (S15D-R58Q versus R58Q) by one-way ANOVA with Tukey's multiple comparison test.
recombinant phosphomimetic S15D-R58Q double mutant that was reconstituted in RLC-depleted porcine cardiac muscle preparations and tested for its functional implications compared to R58Q mutant alone. Our results support an S15D-dependent novel rescue strategy to alleviate a detrimental cardiac phenotype associated with the R58Q mutation in MYL2, found in HCM patients of different ethnic descent to cause a phenotype of severe cardiomyopathy and SCD [20] [21] [22] [23] [24] .
In the RLC molecule, the R58Q mutation replaces the bulky and positively charged arginine with an uncharged but polar glutamine. The mutation lies in the N-terminal domain of the RLC, in close proximity to the cation binding site and to Ser-15 phosphorylation site. Based on I-TASSER modeling, the R58Q mutation results in a decrease in the apparent distance between the mutation and Ser-15 sites, an effect that is normalized with the introduction of S15D in the background of R58Q mutation. Far-UV CD spectra did not reveal any significant changes in the a-helical content as a result of R58Q mutation or its phosphomimic mutation compared to WT RLC. In the absence of loss/gain of a-helical content, it is possible that the extra negative charge from the aspartic acid residue of S15D is able to change the conformation of the Ca 2+ binding loop or the region flanking it, suggesting an allosteric communication between the phosphorylation and Ca 2+ binding sites [7] . As we previously showed, R58Q mutant completely abolished Ca 2+ binding to nonphosphorylated form of RLC and MLCK-induced phosphorylation of R58Q resulted in restoration of Ca 2+ binding with a simultaneous increase in a-helical content [7] .
Porcine cardiac muscle preparations containing physiologically relevant b-MHC isoform were reconstituted with human cardiac RLC mutant proteins to further assess biochemical implications of the HCM-causing mutation and the relevance of the S15D-mediated rescue. Assessing the ability of myosin to strongly bind to actin (under rigor conditions), we show a decrease in the binding affinity because of R58Q mutation compared with WT, and rescue of binding to actin by S15D-R58Q-reconstituted myosin. This clearly suggests that pseudophosphorylation of RLC can play a role in restoration of actin-myosin rigor-state binding. We also evaluated the consequence of the mutation(s) on myosin's enzymatic properties and its interaction with actin. Actin-activated myosin ATPase activity assays showed a significant decrease in maximal ATPase activity (V max ) as a result of R58Q mutation compared with WT myosin. This represents a reduced rate constant of the transition from the weakly bound to strongly bound myosin XBs, most likely conferring a lower myosin duty ratio compared with either WT or S15D-R58Q mutant. Decreased V max may also suggest an R58Q-mediated reduction in the number of functionally accessible myosin heads that are capable of interacting with actin. Consistent with this notion, assessment of myosin's ability to produce contractile force in reconstituted porcine papillary muscle strips revealed an R58Q-dependent decrease in maximal isometric tension without any significant change in myofilament Ca 2+ *P < 0.05. **P < 0.01 versus WT. † P < 0.05. † † P < 0.001 versus R58Q, one-way ANOVA with Tukey's multiple comparison test (porcine system) and t-test (Tg mice). P 1 and P 2 -populations of myosin heads in the fast and slow (respectively) phase of ATP turnover; T 1 and T 2 -nucleotide turnover times (T, lifetime) in the fast and slow (respectively) phase of ATP turnover.
sensitivity. Pseudophosphorylation of R58Q could rescue both the ATPase activity and isometric force to the level of WT.
A small but not significant S15D-mediated increase in the Ca 2+ sensitivity of force was observed between R58Q and S15D-R58Q reconstituted preparations. Similar results were obtained in our earlier study between WT and S15D reconstituted porcine muscle preparations [27] . However, much bigger increase in the Ca 2+ sensitivity of force in these studies was produced by HCM-linked D166V mutation [26, 27] , most likely due to the hypercontractile behavior of D166V mutant. The presence of phosphomimetic mutation in the background of D166V (S15D-D166V) was able to bring the Ca 2+ sensitivity back to that observed for WT-reconstituted strips. Hence, we believe that pseudophosphorylation (in the background of a diseasecausing mutation) will not always tend to increase but rather normalize calcium sensitivity for optimal cardiac performance. Therefore, S15D substitution, by virtue of introducing a negative charge at the phosphorylation site, may be able to either abrogate possible steric constraints introduced by 58Q residue in the conformation-sensitive region of the myosin-lever arm [35] , or introduce structural alterations that may be purely coincidental with the phosphomimetic nature of the mutation, and this largely remains hypothetical and subject of further research.
Myocardium can rapidly downregulate energy output to very low levels during times of stress (e.g., cardiomyopathy mutation), ischemia, or hypoxia [36] . Quantitative epi-fluorescence studies, measuring single nucleotide turnovers, have revealed a new form of highly inhibited state of myosin termed as the SRX, states. R58Q fibers showed a significantly increased P 2 population compared to WT and S15D-R58Q significantly decreased P 2 compared to R58Q mutant. Data are the average AE SEM of n = 16-18 fibers. **P < 0.01 versus WT and *P < 0.05 versus R58Q; by one-way ANOVA with Tukey's multiple comparison test.
with extremely low ATP turnover rates (> 100 s) [29] . In SRX, the myosin heads are highly ordered and interact with one another along the axis of the thick filament forming structures known as the interacting heads motifs (IHMs) [37] . This recently discovered SRX state of myosin motor was shown to be disrupted by myosin RLC phosphorylation [29, 38] . Study from M. Irving laboratory using polarized fluorescence experiments in rat ventricular trabeculae has shown that RLC phosphorylation can shift the equilibrium between perpendicular ON and parallel OFF states toward more ON state of myosin [39] . Using bifunctional sulforhodamine labeled RLCs exchanged into demembranated rat right ventricular trabeculae, the authors further showed that order fluorescence polarization parameter <P 2 > was significantly higher for R58Q under both relaxing (pCa 9) and full calcium activation (pCa 4.3) conditions, suggesting that R58Q mutation induces a more parallel OFF orientation of the myosin heads [40] . They also showed that MLCK-dependent phosphorylation of R58Q RLC-exchanged trabeculae led to an increase by about~30% of maximum active isometric force. While this supports the notion that R58Q promotes an OFF state of the thick filaments, it does not provide information about the effect of R58Q mutation on the number of functional myosin heads that are available for actin interaction and ATP utilization and on the population of myosin head existing in SRX versus DRX state [40] . Our mant-ATP chase experiments in both reconstituted porcine and Tg fibers indicate that R58Q mutation stabilizes the slow SRX phase of myosin compared to WT, and thereby decreases the number of 'working' myosin heads that are able to participate in the force-generating state, without significantly affecting the turnover rate of slow/fast proportion compared to WT. Owing to an unavailability of Tg S15D-R58Q mice, phosphomimetic experiments were limited to reconstituted porcine fibers where we showed an S15D-mediated shift in equilibrium from SRX to DRX compared to R58Q mutant, thereby increasing the proportion of functionally active myosin heads available for the interaction with actin. This effect was in accord with the reduced ATPase activity and diminished isometric force observed for R58Q and their recovery in the presence of the phosphomimetic substitution in the background of mutation. Karabina et al. showed that in the presence of load, porcine myosin bearing the R58Q mutation had largely reduced actin sliding velocity and reduced force production ability compared to WT and that these defects were restored upon mutant phosphorylation [41] . Unlike many HCM mutations, R58Q does not fall into a typical 'hypercontractile' category, as it does not weaken the SRX-IHM state to produce more functionally accessible heads [37] . A common mechanism via which different sarcomeric proteins may induce the development of HCM has yet to be identified. For example, functional effects of different HCM-causing mutations in the MYH7 gene on force generation, ATPase and myofilament Ca 2+ -sensitivity were shown to be quite different, with the force-pCa relationship shifted to the left (hypercontractile) or right (hypocontractile) compared with WT [42] . Similarly, studies with HCM-causing myosin head converter domain mutations suggested a decreased intrinsic force for some of the MYH7 HCM mutations suggesting their hypocontractile behavior [43] . Our recent work on myosin ELC mouse models of HCM demonstrated that two different HCM mutations exerted opposite effects on myosin power output compared to WT ELC and yet led to the same HCM disease in vivo in mice [44] . Along the same lines, recent work from the Houdusse group has shown that various HCM mutations can have disparate effects on the myosin motor function and yet result in similar HCM phenotypes [45] . The question of how different myosin mutations impair the function of myosin leading to the HCM disease will have to be addressed in future high-resolution structural studies.
Concluding remarks
We demonstrate here the feasibility of a robust in vitro molecular rescue strategy to mitigate/prevent functional abnormalities associated with HCM-causing R58Q mutation. We propose that R58Q mutation, by removing the positive charge, may significantly alter the electrostatic interactions in the RLC-MHC hinge interface and thus impair the myosin XBs in their interaction with actin to produce force and muscle contraction. We hypothesize that S15D-R58Q phosphomimic works by virtue of producing a unique structural balance enabling the pseudophosphorylated-R58Q-myosin to abrogate the majority of detrimental biomechanical phenotypes in vitro. We also report on R58Q-mediated stabilization of the SRX population of myosin heads and on S15D-R58Q-induced shift in the SRX↔DRX equilibrium toward the DRX state in which myosin heads can readily interact with thin filaments and produce force.
Overall, our findings strongly support and validate our previous in vitro reports showing phosphomimic rescue in HCM-causing D166V mutation where majority of functional and structural abnormalities were alleviated by S15D in the background of D166V [26, 27] . These in vitro results gave basis to testing the S15D phosphimimic-mediated rescue of HCM phenotype in vivo [12] . We showed that S15D pseudophosphorylation of D166V-RLC mutant was sufficient to prevent the development of HCM in mice [12, 28] . Future studies will explore and evaluate the therapeutic potential of pseudophosphorylation of R58Q-RLC in vivo to rescue its HCM phenotype. The work described in this report is a necessary first step toward applying the S15D strategy in more clinical settings for the management of cardiomyopathies that, among other symptoms, are manifested by depressed levels of RLC phosphorylation.
Materials and methods
All animal procedures and experiments were performed in accordance with the 'Guide for the Care and Use of Laboratory Animals' (NIH Publication 85-23, revised 2011). All the protocols were approved by the Institutional Animal Care and Use Committee at the University of Miami Miller School of Medicine. UM has an Animal Welfare Assurance on file with the Office of Laboratory Animal Welfare (OLAW), NIH. The assurance number is #A-3224-01, effective November 24, 2015. IACUC protocol # is 18-110-LF. Mice were euthanized through CO 2 inhalation followed by cervical dislocation. Tg mouse models with the human ventricular RLC-WT L2 (expressing 100% of human cardiac WT-RLC) and R58Q line-8 (L8, expressing 100% of human cardiac R58Q-RLC) mutant were generated at the University of Miami as previously described [46] .
Mutation, expression, and purification of wildtype (WT) human cardiac RLC and the HCM mutants
Wild-type human cardiac RLC cDNA was cloned via reverse transcription-polymerase chain reaction using primers based on the published cDNA RLC sequence (GenBank TM Accession No. AF020768) using standard methods as described previously [46] . RLC mutants (R58Q and S15D-R58Q) were generated using overlapping sequential polymerase chain reaction as described earlier [27] . Briefly, WT and mutant cDNAs were constructed with an NcoI site upstream of the N-terminal ATG and a BamHI site following the stop codon to facilitate ligation into the NcoIBamHI cloning site of the pET-3d (Novagen, Burlington, MA, USA) plasmid vector and transformation into DH5a cloning host bacteria for expression. The cDNAs were transformed into BL21 expression host cells and all proteins were expressed in large (16 L) cultures. Purification was achieved using an S-Sepharose column (equilibrated with 2 M urea, 20 mM sodium citrate, 0.1 mM PMSF, 1 mM DTT, 0.02% NaN3, pH 6.0), followed by a Q-Sepharose column (equilibrated with 2 M urea, 25 mM Tris-HCl, 0.1 mM PMSF, 1 mM DTT, 0.02% NaN3, pH 7.5). The proteins were eluted with a salt gradient of 0-450 mM NaCl and the final purity was evaluated using 15% SDS/PAGE.
Preparation of porcine cardiac myosin
Porcine cardiac myosin was purified as described in Pant et al. [47] Briefly, ventricular muscle was chilled on ice, washed with ice-cold distilled H 2 O and minced, followed by extraction on ice with stirring for 1.5 h in Edsall-Weber solution (0.012 M Na 2 CO 3 , 0.04 M NaHCO 3 , and 0.6 M KCl, pH 9.0; 300 mL per 100 g of muscle). Then, the homogenate was centrifuged at 13 000 g for 20 min, and the supernatant was precipitated with 13 volumes of water containing 1 mM EDTA and 1 mM DTT. After centrifugation at 13 000 g for 10 min, the pellet was resuspended in buffer containing 0.5M KCl, 20 mM MOPS (pH 7.0), 1 mM DTT, and 10 mM Mg-ATP and centrifuged at 186 000 g for 1.5 h. Supernatant containing native porcine cardiac myosin was precipitated with 13 volumes of ice-cold water and 1 mM DTT and centrifuged at 8000 g for 10 min. The pellets were left on ice overnight. Then, the pellet containing porcine cardiac myosin was dissolved in the above buffer and clarified by centrifugation at 186 000 g for 1.5 h, mixed with glycerol (1 : 1), and stored at À20°C until used.
Depletion of endogenous RLC from porcine cardiac myosin and reconstitution with human cardiac WT or RLC mutants Endogenous RLC was depleted from porcine cardiac myosin by treatment with 1% Triton X-100 and 5 mM CDTA (1, 2-cyclohexylenedinitrilotetraacetic acid), pH 8.5, as described previously [47] . Depleted myosins were then resuspended in a buffer composed of 0.4 M KCl, 50 mM MOPS, 2 mM MgCl 2 , pH 7.0, and 1 mM DTT, mixed in a 1 : 3 molar ratio with recombinant human cardiac RLCs (WT, R58Q or S15D-R58Q), and dialyzed against the same buffer at 4°C for 2 h. RLC-reconstituted myosins were then dialyzed against 5 mM DTT H 2 O overnight. Precipitated myosin-RLC complexes were then collected by centrifugation (2 9 8000 g for 10 min) and resuspended in myosin buffer composed of 0.4 M KCl, 10 mM MOPS, pH 7.0, and 1 mM DTT. Samples were taken for SDS/PAGE analysis before they were mixed 1 : 1 with glycerol and stored at À20°C until needed for experiments. At least 3-4 isolated preparations of recombinant RLC-reconstituted myosins were used for all the assays involving reconstituted porcine myosin.
Preparation of skeletal muscle F-actin
Rabbit skeletal muscle F-actin was prepared as described previously [27] . Briefly, extraction of rabbit skeletal acetone powder was achieved with G-actin buffer consisting of 2 mM Tris-HCl (pH 8.0), 0.2 mM Na 2 ATP, 0.5 mM b-mercaptoethanol, 0.2 mM CaCl 2 , and 0.0005% NaN 3 at a ratio of 20 mLÁg À1 for 30 min with stirring on ice. The extract was then clarified by centrifugation at 7000 g at 4°C for 1 h. The pellet was discarded, and the supernatant was adjusted to a final concentration of 40 mM KCl, 2 mM MgCl 2 , and 1 mM Na 2 ATP (pH 8.0). F-actin was allowed to polymerize for 2 h at 4°C. The KCl concentration was slowly increased to a final concentration of 0.6 M, and the solution was slowly stirred on ice for 30 min to remove any possible traces of tropomyosin-troponin. F-actin was collected by ultracentrifugation at 160 000 g at 4°C for 1.5 h. The supernatant was discarded, and the F-actin pellets were redissolved in a buffer consisting of 10 mM MOPS (pH 7.0) and 40 mM KCl and stored in liquid nitrogen until further use.
Labeling of F-actin with pyrene
Rabbit skeletal actin was fluorescently labeled with pyrene iodoacetamide (PIA) as described in Muthu et al. [27] . Briefly, 20-40 lM F-actin was incubated at room temperature, in the dark, for 16 h with a 1.5 molar excess of N-(1-pyrene) iodoacetamide (Invitrogen: Carlsbad, CA, USA, Molecular Probes) in a buffer containing 10 mM MOPS, 1 mM MgCl 2 , and 40 mM KCl at pH 7.0. Then, the reaction was quenched with 1 mM DTT and the preparation was centrifuged at 1000 g for 1 h. F-actin was dialyzed against G-actin buffer (2 mM Tris-HCl pH 8.0, 0.2 mM CaCl 2 , 0.2 mM ATP, 1 mM DTT) to remove excess of pyrene and was allowed to polymerize overnight to form Factin. The resulting molar ratio of pyrene/F-actin was 0.87 determined using the molar extinction coefficient, e 344 (pyrene) = 22 000 M À1 cm À1 .
Binding of porcine myosin reconstituted with RLC to pyrene-labeled F-actin
Pyrene-labeled F-actin at a concentration of 0.5 lM (stabilized by 0.5 lM phalloidin) was titrated with porcine myosin reconstituted with WT, R58Q, and S15D-R58Q RLCs, from 0.05 to 1 lM, in 0.05 lM increments until it reached stoichiometrical saturation. Fluorescence measurements were done using a JASCO 6500 spectrofluorometer. PIA was excited at 340 nm and fluorescence was collected at 407 nm. The titration data were fitted to the following quadratic equation to obtain the binding constant (K d ) and stoichiometry (n):
where m1 is the initial signal (fluorescence intensity at 0 lM myosin), m2 is the maximal amplitude (fluorescence intensity at saturating myosin concentrations), n is the stoichiometry of binding (mole of myosin per mole of actin), and x is the total concentration of added myosin.
Stopped-flow measurements
Porcine cardiac myosins reconstituted with WT, R58Q, and S15D-R58Q recombinant RLC proteins at concentrations of 0.25 lM were mixed with 0.25 lM pyrene-labeled F-actin (stabilized by 0.25 lM phalloidin) in rigor buffer containing 0.4 M KCl, 1 mM DTT, and 10 mM MOPS at pH 7.0. The complexes were mixed in a 1 : 1 ratio (vol/vol) with increasing concentrations of Mg-ATP (10-250 lM) dissolved in the same buffer. Mg-ATP-dependent dissociation of RLC-reconstituted myosins from labeled F-actin was observed by monitoring the time course of the change in pyrene fluorescence. Measurements were performed at 21°C using a BioLogic (Claix, France) model SFM-20 stopped-flow instrument outfitted with a Berger ball mixer and an FC-8 observation cuvette. Data were collected and digitized using a JASCO 6500 fluorometer with an estimated dead time of 3.5 ms. Pyrene-F-actin was excited at 347 nm, and emission was monitored at 404 nm using monochromators set at 20-nm bandwidths. Typically, 7-13 stopped-flow records were averaged and fit to a singleexponential equation to obtain the apparent rate constant, k obs (s À1 ), at a given Mg-ATP concentration. Observed myosin dissociation rates were plotted as a function of [Mg-ATP] and fitted to the following hyperbolic equation:
where K 1 is the association constant for Mg-ATP to XBs (in M
À1
), which is the reciprocal of the dissociation constant (1/K 1 ); S is the concentration of Mg-ATP (expressed in M); and k +2 is the maximal observed rate constant at saturating Mg-ATP (expressed in s À1 ), which reflect the XB detachment [48] .
Actin-activated myosin ATPase assays
Actomyosin interaction kinetics was assessed using the Factin-activated myosin ATPase activity assays. Reconstituted porcine myosin preparations, previously stored 1 : 1 in glycerol, were precipitated with 13 volumes of ice-cold 2 mM DTT H 2 O and collected by centrifugation at 2 9 8000 g for 10 min. Myosin pellets were resuspended in 0.4 M KCl, 10 mM MOPS, and 1 mM DTT at pH 7.0, and then dialyzed overnight at 4°C against the same buffer. Myosin concentrations were determined using Coomassie Plus protein assay (Pierce, Rockford, IL, USA). Myosin at a final concentration of 1.1 lM was titrated with increasing amounts of rabbit skeletal F-actin (in lM): 0.1, 0.3, 1, 2.5, 5, 7.5, 10, and 20 [27] . The assays were performed in triplicate on 96-well microplates in a 120 lL reaction volume containing 25 mM imidazole, 4 mM MgCl 2 , 1 mM EGTA, and 1 mM DTT at pH 7.0. The final KCl salt concentration was 76.7 mM. The reactions were initiated with the addition of 2.5 mM ATP with mixing in a Jitterbug incubator shaker and allowed to proceed for 20 min at 30°C. Termination of the reaction was achieved by addition of ice-cold trichloroacetic acid at a final concentration of 4%. Precipitated proteins were cleared by centrifugation, and the inorganic phosphate was determined according to the Fiske and Subbarow method [49] . Data were analyzed using the Michaelis-Menten equation, yielding Vmax and K m [50] .
Skinned porcine papillary muscle fibers
Freshly isolated porcine hearts were placed in oxygenated physiological salt solution of 140 mM NaCl, 4 mM KCl, 
ATP chase experiments
Nucleotide exchange experiments were performed in: (a) Porcine papillary muscle fibers, depleted and reconstituted with recombinant WT, R58Q, S15D-R58Q RLC proteins and (b) Tg R58Q, WT mouse cardiac papillary muscles (S15D-R58Q mice model was not available). Transgenic RLC-WT and RLC-R58Q mice were euthanized using CO 2 inhalation, and the hearts were rapidly excised and rinsed in pCa 8 solution supplemented with 15% glycerol and 30 mM 2,3-butanedione monoxime. Intact papillary muscles were dissected from the left ventricle and the fibers were chemically skinned with 1% Triton X-100 and 50/50 (%) pCa 8 and glycerol overnight at À4°C. This removal of membranes allows modulation of the myofilament chemical environment.
The skinned Tg mouse PM muscle strips were manually dissected into small fiber bundles having a diameter of 80-100 lm. The same diameter was also observed for RLCdepleted and mutant-reconstituted porcine PM used in the mant-ATP experiments. The fibers were washed with pCa 8 solution followed with three washes with basic rigor buffer containing 120 mM KAcetate, 5 mM MgAcetate, 2.5 mM K 2 HPO 4 , 2.5 mM KH 2 PO 4 , and 50 mM 3-(n-morpholino) propanesulfonic acid, pH 6.8, with fresh 2 mM DTT. Then, the fibers were taped firmly on a glass slide and covered with a cover slip forming a simple flow chamber and were incubated for several minutes with 250 lM mant-ATP (in rigor buffer) until maximum fluorescence was achieved. The chase experiments were performed using Ionoptix Calcium and Contractility Recording System equipped with hyperSwitch dual excitation light source (with sub-millisecond switching times) and inverted fluorescence microscope with MyoCam-S TM digital variable field rate CCD video system. Excitation was achieved via the 340 nm filter with a 12 nm bandpass and emission was recorded by 510 nm filter with a 40 nm bandpass. Subsequently, mant-ATP was chased with 4 mM unlabeled ATP (in rigor buffer) that resulted in a decrease in fluorescence intensity as the hydrolyzed mant-ATP was exchanged for ATP. The sarcomere length of fibers varied from 1.9 to 2.1 lm and was not found to influence the fluorescence decays. Fluorescence intensity, I, as a function of time, t, was fit using a two-exponential decay function (see Results) with P 1 and P 2 depicting the amplitudes of fiber fluorescence fractions characterized by the fast T 1 and slow T 2 fluorescence lifetimes. Fitting was done using a nonlinear least-squares algorithm in GRAPHPAD PRISM version 7 (Graphpad, La Jolla, CA, USA).
Steady-state force measurements
Porcine papillary muscle strips (~1.4 mm in length and 100 lm in diameter), reconstituted with recombinant RLC proteins, were attached to a force transducer of the Guth muscle research system, placed in a 1 mL cuvette and freshly skinned in 1% Triton X-100 dissolved in pCa 8 buffer for 30 min to remove the remaining membrane and ECM (extracellular matrix) proteins. Next, the fibers were washed three times for 5 min in pCa 8 buffer and their lengths were adjusted to remove the slack. This procedure resulted in sarcomere length of 2.1-2.2 lm as judged by the first order optical diffraction pattern as described in Yuan et al. [12] . Then the maximal steady-state force was measured in pCa 4 solution ([Ca 2+ ] = 10 À4 M). Maximal tension readings (in pCa 4) were taken before and after the force-pCa curve, averaged and expressed in kNÁm À2 with the cross-sectional area assumed to be circular. The measurement of fiber diameter was taken at $ 3 points along the fiber length with an SZ6045 Olympus microscope (zoom ratio of 6.3 : 1, up to 9 189 maximum magnification) and averaged. Maximal steady-state force (pCa 4) was determined for all RLC recombinant proteins: WT, R58Q, and S15D-R58Q reconstituted in RLC-depleted skinned porcine cardiac muscle strips. All mechanical experiments on glycerinated skinned papillary muscle fibers were carried out at room temperature (22°C).
Ca

2+ -dependence of force development
After the initial steady-state force was determined, the muscle strips were relaxed in pCa 8 buffer and were then exposed to solutions of increasing Ca 2+ concentration from pCa 8 to pCa 4. The level of force was measured in each 'pCa' solution. Data were analyzed using the Hill equation [51] , yielding the pCa 50 (free Ca 2+ concentration which produces 50% of the maximal force) and n H (Hill coefficient). The pCa 50 represents the measure of Ca 2+ sensitivity of force and the n H is the measure of myofilament cooperativity.
Secondary structure prediction of RLCs
The secondary structure predictions were conducted with the I-TASSER online server from Zhang lab at the University of Michigan (http://zhanglab.ccmb.med.umich.edu/I-TASSER/). In brief, the amino acid sequences of WT, R58Q, and S15D-R58Q RLCs were compared against template proteins of similar structure chosen from the PDB library. The full-length protein was assembled from excised fragments and simulated into the lowest-energy model using specific algorithms. The confidence of each predicted model structure was presented as C-score, ranging from À5 to 2, which was proportional to the quality of prediction [31, 32] . The predicted structures were then modeled using PyMOL molecular visualization system allowing determination of the distances, in Angstroms ( A), between C-a of the neighboring amino acids.
CD measurements
Circular dichroism (CD) spectroscopy, a form of light absorption spectroscopy that measures the difference in absorbance of right and left circularly polarized light, is very sensitive to the secondary structure of polypeptides and proteins. Far-UV circular dichroism spectra were acquired using a 1-mm path quartz cell in a Jasco J-720 spectropolarimeter. Spectra were recorded at 195-250 nm with a bandwidth of 1 nm at a speed of 50 nmÁmin À1 and a resolution of 0.2 nm.
Analysis and processing of data were done using the JASCO SYSTEM software (Jasco, Easton, MD, USA) (Windows Standard Analysis, version 1.20). Ten scans were averaged, and base line buffer optical activities were subtracted with no numerical smoothing. Mean residue ellipticity ([h] MRE , in degreesÁcm 2 per dmol) for the spectra were calculated (utilizing the same JASCO SYSTEM software) using the following equation:
½h MRE ¼ ½h=ð10 Â Cr Â lÞ
[h] is the measured ellipticity in millidegrees, Cr is the mean residue molar concentration, and l is the path length in cm. The a-helical content for each protein was calculated using the following standard equation for [h] at 222 nm:
f H is the fraction of a-helical content (f H 9 100, expressed in %). The measurements were performed at 22°C in 30 mM NaCl, and 0.3 mM EGTA, 0.7 mM MgCl 2 , 3 mM Tris-HCl at pH 7.4. Spectra are presented as the mean residue ellipticity.
SDS/PAGE
Preparations of control, CDTA-depleted and WT, R58Q, and S15D-R58Q reconstituted porcine cardiac myosins and skinned muscle strips were run on 15% SDS/PAGE. Bands were visualized by Coomassie blue G-250. Respective RLC protein bands were quantified using ImageJ (https://imagej. nih.gov/ij/). RLC depletion and/or reconstitution were quantified from the band intensity of the RLC and ELC proteins according to the equation:
where RLC nat and ELC nat depict the level of RLC and ELC in control untreated muscle strips. ELC protein was used as a loading control.
Statistical analyses
All values are shown as means AE SD (standard deviation) or AE SEM (standard error of the mean). Statistically significant differences between two groups were determined using an unpaired Student's t-test and comparisons between multiple groups were performed using one-way ANOVA and the Tukey's multiple comparison test. Extra sum-of-squares F-test was used to compare the goodness-of-fit of nested models for stopped-flow data curves (GRAPHPAD PRISM 7). Significance was defined as *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001.
